Global Spatial Genomics Market Key Players Competitive Survey Report 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Spatial Genomics market size in 2022 is 204.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 11.60% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Spatial Genomics market include Thermo Fisher Scientific Inc. (U.S.), 10X Genomics (U.S.), NanoString Technologies Inc. (U.S.), Illumina Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.). The share of the top 3 players in the Spatial Genomics market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Spatial Genomics market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Fluorescence in situ hybridization (FISH) accounted for XX% of Spatial Genomics market in 2022. Microscopy-based Live DNA Imaging share of XX%.
Translational Research accounted for XX% of the Spatial Genomics market in 2022. Academic Customers accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Spatial Genomics market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Spatial Genomics market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Spatial Genomics market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Spatial Genomics market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Spatial Genomics industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Market Data Breakdown by Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some prominent players in the market includes:
Thermo Fisher Scientific Inc. (U.S.)
10X Genomics (U.S.)
NanoString Technologies Inc. (U.S.)
Illumina Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
QIAGEN (Netherlands)
Agilent Technologies, Inc. (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
S2 Genomics, Inc. (U.S.)
Seven Bridges Genomics (U.S.)
CARTANA AB (Sweden)
READCOOR, INC (U.S.)
Advanced Cell Diagnostics, Inc. (U.S.)
Dovetail Genomics (U.S.)
Novartis AG (Switzerland)
Pfizer Inc. (U.S.)
Merck & Co., Inc. (Germany)
Novo Nordisk A/S (Denmark)
Amgen Inc. (U.S.)
Johnson & Johnson Services, Inc. (U.S.)
Gsk plc (U.K.)
Bayer AG (Germany)
Market Data Breakdown by Type
Fluorescence in situ hybridization (FISH)
Microscopy-based Live DNA Imaging
Genome Perturbation Tools
Massively-Parallel Sequencing
Biochemical Techniques
Others
Market Data Breakdown by Applications
Translational Research
Academic Customers
Diagnostic Customers
Pharmaceutical Manufacturer
Government Institutes and Academic Centers
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Table of Content
1 Spatial Genomics Market Introduction and Overview
1.1 Spatial Genomics Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Spatial Genomics Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Spatial Genomics Revenue and Market Share by Type
3 Global Spatial Genomics Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Spatial Genomics Revenue Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Spatial Genomics Market Size (2018-2023)
4.2 Spatial Genomics Growth Trends Analysis by Regions
4.2.1 Spatial Genomics Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Spatial Genomics Historic Revenue Market Size by Regions (2018-2023)
4.2.3 North America Spatial Genomics Market Size (2018-2023)
4.2.4 Europe Spatial Genomics Market Size (2018-2023)
4.2.5 Asia-Pacific Spatial Genomics Market Size (2018-2023)
4.2.6 Latin America Spatial Genomics Market Size (2018-2023)
4.2.7 Middle East & Africa Spatial Genomics Market Size (2018-2023)
5 North America
5.1 North America Spatial Genomics Revenue by Countries
5.1.1 North America Spatial Genomics Revenue by Countries (2018-2023)
5.2 North America Spatial Genomics Revenue by Types
5.3 North America Spatial Genomics Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Spatial Genomics Revenue by Countries
6.1.1 Asia Pacific Spatial Genomics Revenue by Countries (2018-2023)
6.2 Asia Pacific Spatial Genomics Revenue by Types
6.3 Asia Pacific Spatial Genomics Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Spatial Genomics Revenue by Countries
7.1.1 Europe Spatial Genomics Revenue by Countries (2018-2023)
7.2 Europe Spatial Genomics Revenue by Types
7.3 Europe Spatial Genomics Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Spatial Genomics Revenue by Countries
8.1.1 Latin America Spatial Genomics Revenue by Countries (2018-2023)
8.2 Latin America Spatial Genomics Revenue by Types
8.3 Latin America Spatial Genomics Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Spatial Genomics Revenue by Countries
9.1.1 Middle East & Africa Spatial Genomics Revenue by Countries (2018-2023)
9.2 Middle East & Africa Spatial Genomics Revenue by Types
9.3 Middle East & Africa Spatial Genomics Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Spatial Genomics Market Competition, by Players
10.1 Global Spatial Genomics Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Spatial Genomics Players Market Share in 2022
10.2.2 Top 6 Spatial Genomics Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Spatial Genomics Players Head Office, Business Provided
10.4 Spatial Genomics Mergers & Acquisitions
10.5 Spatial Genomics New Entrants and Expansion Plans
11 Players Profiles11.1 Thermo Fisher Scientific Inc. (U.S.)
11.1.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile
11.1.2 Spatial Genomics Product Overview
11.1.3 Thermo Fisher Scientific Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.1.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 10X Genomics (U.S.)
11.2.1 10X Genomics (U.S.) Company Profile
11.2.2 Spatial Genomics Product Overview
11.2.3 10X Genomics (U.S.) Spatial Genomics Market Performance (2018-2023)
11.2.4 10X Genomics (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 NanoString Technologies Inc. (U.S.)
11.3.1 NanoString Technologies Inc. (U.S.) Company Profile
11.3.2 Spatial Genomics Product Overview
11.3.3 NanoString Technologies Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.3.4 NanoString Technologies Inc. (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Illumina Inc. (U.S.)
11.4.1 Illumina Inc. (U.S.) Company Profile
11.4.2 Spatial Genomics Product Overview
11.4.3 Illumina Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.4.4 Illumina Inc. (U.S.) Business Overview
11.4.5 Recent Developments and Plans
11.5 Bio-Rad Laboratories, Inc. (U.S.)
11.5.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile
11.5.2 Spatial Genomics Product Overview
11.5.3 Bio-Rad Laboratories, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.5.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
11.5.5 Recent Developments and Plans
11.6 QIAGEN (Netherlands)
11.6.1 QIAGEN (Netherlands) Company Profile
11.6.2 Spatial Genomics Product Overview
11.6.3 QIAGEN (Netherlands) Spatial Genomics Market Performance (2018-2023)
11.6.4 QIAGEN (Netherlands) Business Overview
11.6.5 Recent Developments and Plans
11.7 Agilent Technologies, Inc. (U.S.)
11.7.1 Agilent Technologies, Inc. (U.S.) Company Profile
11.7.2 Spatial Genomics Product Overview
11.7.3 Agilent Technologies, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.7.4 Agilent Technologies, Inc. (U.S.) Business Overview
11.7.5 Recent Developments and Plans
11.8 F. Hoffmann-La Roche Ltd. (Switzerland)
11.8.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile
11.8.2 Spatial Genomics Product Overview
11.8.3 F. Hoffmann-La Roche Ltd. (Switzerland) Spatial Genomics Market Performance (2018-2023)
11.8.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
11.8.5 Recent Developments and Plans
11.9 S2 Genomics, Inc. (U.S.)
11.9.1 S2 Genomics, Inc. (U.S.) Company Profile
11.9.2 Spatial Genomics Product Overview
11.9.3 S2 Genomics, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.9.4 S2 Genomics, Inc. (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Seven Bridges Genomics (U.S.)
11.10.1 Seven Bridges Genomics (U.S.) Company Profile
11.10.2 Spatial Genomics Product Overview
11.10.3 Seven Bridges Genomics (U.S.) Spatial Genomics Market Performance (2018-2023)
11.10.4 Seven Bridges Genomics (U.S.) Business Overview
11.10.5 Recent Developments and Plans
11.11 CARTANA AB (Sweden)
11.11.1 CARTANA AB (Sweden) Company Profile
11.11.2 Spatial Genomics Product Overview
11.11.3 CARTANA AB (Sweden) Spatial Genomics Market Performance (2018-2023)
11.11.4 CARTANA AB (Sweden) Business Overview
11.11.5 Recent Developments and Plans
11.12 READCOOR, INC (U.S.)
11.12.1 READCOOR, INC (U.S.) Company Profile
11.12.2 Spatial Genomics Product Overview
11.12.3 READCOOR, INC (U.S.) Spatial Genomics Market Performance (2018-2023)
11.12.4 READCOOR, INC (U.S.) Business Overview
11.12.5 Recent Developments and Plans
11.13 Advanced Cell Diagnostics, Inc. (U.S.)
11.13.1 Advanced Cell Diagnostics, Inc. (U.S.) Company Profile
11.13.2 Spatial Genomics Product Overview
11.13.3 Advanced Cell Diagnostics, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.13.4 Advanced Cell Diagnostics, Inc. (U.S.) Business Overview
11.13.5 Recent Developments and Plans
11.14 Dovetail Genomics (U.S.)
11.14.1 Dovetail Genomics (U.S.) Company Profile
11.14.2 Spatial Genomics Product Overview
11.14.3 Dovetail Genomics (U.S.) Spatial Genomics Market Performance (2018-2023)
11.14.4 Dovetail Genomics (U.S.) Business Overview
11.14.5 Recent Developments and Plans
11.15 Novartis AG (Switzerland)
11.15.1 Novartis AG (Switzerland) Company Profile
11.15.2 Spatial Genomics Product Overview
11.15.3 Novartis AG (Switzerland) Spatial Genomics Market Performance (2018-2023)
11.15.4 Novartis AG (Switzerland) Business Overview
11.15.5 Recent Developments and Plans
11.16 Pfizer Inc. (U.S.)
11.16.1 Pfizer Inc. (U.S.) Company Profile
11.16.2 Spatial Genomics Product Overview
11.16.3 Pfizer Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.16.4 Pfizer Inc. (U.S.) Business Overview
11.16.5 Recent Developments and Plans
11.17 Merck & Co., Inc. (Germany)
11.17.1 Merck & Co., Inc. (Germany) Company Profile
11.17.2 Spatial Genomics Product Overview
11.17.3 Merck & Co., Inc. (Germany) Spatial Genomics Market Performance (2018-2023)
11.17.4 Merck & Co., Inc. (Germany) Business Overview
11.17.5 Recent Developments and Plans
11.18 Novo Nordisk A/S (Denmark)
11.18.1 Novo Nordisk A/S (Denmark) Company Profile
11.18.2 Spatial Genomics Product Overview
11.18.3 Novo Nordisk A/S (Denmark) Spatial Genomics Market Performance (2018-2023)
11.18.4 Novo Nordisk A/S (Denmark) Business Overview
11.18.5 Recent Developments and Plans
11.19 Amgen Inc. (U.S.)
11.19.1 Amgen Inc. (U.S.) Company Profile
11.19.2 Spatial Genomics Product Overview
11.19.3 Amgen Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.19.4 Amgen Inc. (U.S.) Business Overview
11.19.5 Recent Developments and Plans
11.20 Johnson & Johnson Services, Inc. (U.S.)
11.20.1 Johnson & Johnson Services, Inc. (U.S.) Company Profile
11.20.2 Spatial Genomics Product Overview
11.20.3 Johnson & Johnson Services, Inc. (U.S.) Spatial Genomics Market Performance (2018-2023)
11.20.4 Johnson & Johnson Services, Inc. (U.S.) Business Overview
11.20.5 Recent Developments and Plans
11.21 Gsk plc (U.K.)
11.21.1 Gsk plc (U.K.) Company Profile
11.21.2 Spatial Genomics Product Overview
11.21.3 Gsk plc (U.K.) Spatial Genomics Market Performance (2018-2023)
11.21.4 Gsk plc (U.K.) Business Overview
11.21.5 Recent Developments and Plans
11.22 Bayer AG (Germany)
11.22.1 Bayer AG (Germany) Company Profile
11.22.2 Spatial Genomics Product Overview
11.22.3 Bayer AG (Germany) Spatial Genomics Market Performance (2018-2023)
11.22.4 Bayer AG (Germany) Business Overview
11.22.5 Recent Developments and Plans
12 Global Spatial Genomics Forecast Market Analysis by Type
12.1 Global Spatial Genomics Revenue Market Forecast by Type (2023-2029)
13 Global Spatial Genomics Forecast Market Analysis by Application
13.1 Spatial Genomics Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Spatial Genomics Forecast Market Size (2023-2029)
14.2 Spatial Genomics Growth Trends Forecast Analysis by Regions
14.2.1 Spatial Genomics Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Spatial Genomics Forecast Market Size (2023-2029)
14.2.3 Europe Spatial Genomics Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Spatial Genomics Forecast Market Size (2023-2029)
14.2.5 Latin America Spatial Genomics Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Spatial Genomics Forecast Market Size (2023-2029)
15 Spatial Genomics Industry Dynamic Analysis
15.1 Spatial Genomics Market Trends Analysis
15.2 Spatial Genomics Market Drivers Analysis
15.3 Spatial Genomics Market Challenges Analysis
15.4 Spatial Genomics Market Restraints Analysis
Tables & Figures:
List of Tables and Figures
Figure Spatial Genomics Picture
Table Product Definition of Spatial Genomics
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Spatial Genomics Market Size by Type (2018 VS 2023 VS 2029)
Table Global Spatial Genomics Revenue and Market Size by Type (2018-2023)
Table Global Spatial Genomics Revenue and Market Share by Type (2018-2023)
Table Global Spatial Genomics Market Size by Application (2018 VS 2023 VS 2029)
Table Global Spatial Genomics Revenue Market Size by Application (2018-2023)
Table Global Spatial Genomics Revenue Market Share by Application (2018-2023)
Figure Global Spatial Genomics Revenue Market Size (2018-2023)
Table Spatial Genomics Market Size by Regions: 2018 VS 2023 VS 2029
Table Spatial Genomics Historic Revenue Market Size by Regions (2018-2023)
Table Spatial Genomics Historic Revenue Market Share by Regions (2018-2023)
Figure North America Spatial Genomics Market Size (2018-2023)
Figure Europe Spatial Genomics Market Size (2018-2023)
Figure Asia-Pacific Spatial Genomics Market Size (2018-2023)
Figure Latin America Spatial Genomics Market Size (2018-2023)
Figure Middle East & Africa Spatial Genomics Market Size (2018-2023)
Table North America Spatial Genomics Revenue by Countries (2018-2023)
Table North America Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table North America Spatial Genomics Revenue by Types (2018-2023)
Table North America Spatial Genomics Revenue Market Share by Types (2018-2023)
Table North America Spatial Genomics Revenue by Applications (2018-2023)
Table North America Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure United States Spatial Genomics Revenue and Growth (2018-2023)
Figure Canada Spatial Genomics Revenue and Growth (2018-2023)
Table Asia-Pacific Spatial Genomics Revenue by Countries (2018-2023)
Table Asia-Pacific Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table Asia Pacific Spatial Genomics Revenue by Types (2018-2023)
Table Asia Pacific Spatial Genomics Revenue Market Share by Types (2018-2023)
Table Asia Pacific Spatial Genomics Revenue by Applications (2018-2023)
Table Asia Pacific Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure China Spatial Genomics Revenue and Growth (2018-2023)
Figure Japan Spatial Genomics Revenue and Growth (2018-2023)
Figure Korea Spatial Genomics Revenue and Growth (2018-2023)
Figure Southeast Asia Spatial Genomics Revenue and Growth (2018-2023)
Figure India Spatial Genomics Revenue and Growth (2018-2023)
Figure Australia Spatial Genomics Revenue and Growth (2018-2023)
Table Europe Spatial Genomics Revenue by Countries (2018-2023)
Table Europe Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table Europe Spatial Genomics Revenue by Types (2018-2023)
Table Europe Spatial Genomics Revenue Market Share by Types (2018-2023)
Table Europe Spatial Genomics Revenue by Applications (2018-2023)
Table Europe Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure Germany Spatial Genomics Revenue and Growth (2018-2023)
Figure France Spatial Genomics Revenue and Growth (2018-2023)
Figure UK Spatial Genomics Revenue and Growth (2018-2023)
Figure Italy Spatial Genomics Revenue and Growth (2018-2023)
Figure Russia Spatial Genomics Revenue and Growth (2018-2023)
Figure Spain Spatial Genomics Revenue and Growth (2018-2023)
Figure Nordic Spatial Genomics Revenue and Growth (2018-2023)
Table Latin America Spatial Genomics Revenue by Countries (2018-2023)
Table Latin America Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table Latin America Spatial Genomics Revenue by Types (2018-2023)
Table Latin America Spatial Genomics Revenue Market Share by Types (2018-2023)
Table Latin America Spatial Genomics Revenue by Applications (2018-2023)
Table Latin America Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure Brazil Spatial Genomics Revenue and Growth (2018-2023)
Figure Argentina Spatial Genomics Revenue and Growth (2018-2023)
Figure Mexico Spatial Genomics Revenue and Growth (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue by Countries (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue Market Share by Countries (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue by Types (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue Market Share by Types (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue by Applications (2018-2023)
Table Middle East & Africa Spatial Genomics Revenue Market Share by Applications (2018-2023)
Figure Egypt Spatial Genomics Revenue and Growth (2018-2023)
Figure South Africa Spatial Genomics Revenue and Growth (2018-2023)
Figure UAE Spatial Genomics Revenue and Growth (2018-2023)
Figure Turkey Spatial Genomics Revenue and Growth (2018-2023)
Figure Saudi Arabia Spatial Genomics Revenue and Growth (2018-2023)
Table Global Spatial Genomics Revenue by Players (2018-2023)
Table Global Spatial Genomics Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Spatial Genomics Players Market Concentration Ratio (CR5) (2018-2023)
Table Spatial Genomics Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Thermo Fisher Scientific Inc. (U.S.) Profile
Table Product Overview
Table Thermo Fisher Scientific Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Thermo Fisher Scientific Inc. (U.S.) Revenue and Growth Rate
Figure Thermo Fisher Scientific Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table 10X Genomics (U.S.) Profile
Table Product Overview
Table 10X Genomics (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure 10X Genomics (U.S.) Revenue and Growth Rate
Figure 10X Genomics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table NanoString Technologies Inc. (U.S.) Profile
Table Product Overview
Table NanoString Technologies Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure NanoString Technologies Inc. (U.S.) Revenue and Growth Rate
Figure NanoString Technologies Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Illumina Inc. (U.S.) Profile
Table Product Overview
Table Illumina Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Illumina Inc. (U.S.) Revenue and Growth Rate
Figure Illumina Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bio-Rad Laboratories, Inc. (U.S.) Profile
Table Product Overview
Table Bio-Rad Laboratories, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Bio-Rad Laboratories, Inc. (U.S.) Revenue and Growth Rate
Figure Bio-Rad Laboratories, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table QIAGEN (Netherlands) Profile
Table Product Overview
Table QIAGEN (Netherlands) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure QIAGEN (Netherlands) Revenue and Growth Rate
Figure QIAGEN (Netherlands) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Agilent Technologies, Inc. (U.S.) Profile
Table Product Overview
Table Agilent Technologies, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Agilent Technologies, Inc. (U.S.) Revenue and Growth Rate
Figure Agilent Technologies, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table F. Hoffmann-La Roche Ltd. (Switzerland) Profile
Table Product Overview
Table F. Hoffmann-La Roche Ltd. (Switzerland) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue and Growth Rate
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table S2 Genomics, Inc. (U.S.) Profile
Table Product Overview
Table S2 Genomics, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure S2 Genomics, Inc. (U.S.) Revenue and Growth Rate
Figure S2 Genomics, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Seven Bridges Genomics (U.S.) Profile
Table Product Overview
Table Seven Bridges Genomics (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Seven Bridges Genomics (U.S.) Revenue and Growth Rate
Figure Seven Bridges Genomics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table CARTANA AB (Sweden) Profile
Table Product Overview
Table CARTANA AB (Sweden) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure CARTANA AB (Sweden) Revenue and Growth Rate
Figure CARTANA AB (Sweden) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table READCOOR, INC (U.S.) Profile
Table Product Overview
Table READCOOR, INC (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure READCOOR, INC (U.S.) Revenue and Growth Rate
Figure READCOOR, INC (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Advanced Cell Diagnostics, Inc. (U.S.) Profile
Table Product Overview
Table Advanced Cell Diagnostics, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Advanced Cell Diagnostics, Inc. (U.S.) Revenue and Growth Rate
Figure Advanced Cell Diagnostics, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Dovetail Genomics (U.S.) Profile
Table Product Overview
Table Dovetail Genomics (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Dovetail Genomics (U.S.) Revenue and Growth Rate
Figure Dovetail Genomics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Novartis AG (Switzerland) Profile
Table Product Overview
Table Novartis AG (Switzerland) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Novartis AG (Switzerland) Revenue and Growth Rate
Figure Novartis AG (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Pfizer Inc. (U.S.) Profile
Table Product Overview
Table Pfizer Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Pfizer Inc. (U.S.) Revenue and Growth Rate
Figure Pfizer Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Merck & Co., Inc. (Germany) Profile
Table Product Overview
Table Merck & Co., Inc. (Germany) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Merck & Co., Inc. (Germany) Revenue and Growth Rate
Figure Merck & Co., Inc. (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Novo Nordisk A/S (Denmark) Profile
Table Product Overview
Table Novo Nordisk A/S (Denmark) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Novo Nordisk A/S (Denmark) Revenue and Growth Rate
Figure Novo Nordisk A/S (Denmark) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Amgen Inc. (U.S.) Profile
Table Product Overview
Table Amgen Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Amgen Inc. (U.S.) Revenue and Growth Rate
Figure Amgen Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Johnson & Johnson Services, Inc. (U.S.) Profile
Table Product Overview
Table Johnson & Johnson Services, Inc. (U.S.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Johnson & Johnson Services, Inc. (U.S.) Revenue and Growth Rate
Figure Johnson & Johnson Services, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Gsk plc (U.K.) Profile
Table Product Overview
Table Gsk plc (U.K.) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Gsk plc (U.K.) Revenue and Growth Rate
Figure Gsk plc (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bayer AG (Germany) Profile
Table Product Overview
Table Bayer AG (Germany) Spatial Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Bayer AG (Germany) Revenue and Growth Rate
Figure Bayer AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Spatial Genomics Revenue Market Size Forecast by Type (2023-2029)
Table Global Spatial Genomics Revenue Market Share Forecast by Type (2023-2029)
Table Global Spatial Genomics Revenue Market Size by Application (2023-2029)
Table Global Spatial Genomics Revenue Market Share by Application (2023-2029)
Figure Global Spatial Genomics Revenue Forecast Market Size (2023-2029)
Table Spatial Genomics Revenue Forecast Market Size by Regions (2023-2029)
Table Spatial Genomics Revenue Forecast Market Share by Regions (2023-2029)
Figure North America Spatial Genomics Revenue Forecast Market Size (2023-2029)
Figure Europe Spatial Genomics Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Spatial Genomics Revenue Forecast Market Size (2023-2029)
Figure Latin America Spatial Genomics Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa Spatial Genomics Revenue Forecast Market Size (2023-2029)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Research Methodology:
Global Spatial Genomics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|